Dr. Diana Buist reflects on the challenges of providing screening during a pandemic — and finds reason for optimism.
The investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of about 94% as research continues.
This year’s honorees inspire us with their unwavering dedication to helping colleagues grow and achieve – even from a distance.
KPWHRI responded to the COVID-19 hurricane with actions to improve health worldwide.
In a Viewpoint for JAMA, KPWHRI’s Dr. Mike Jackson plans ahead to meet the challenges of continuing to evaluate new vaccines.
Experts in health data discuss a widely used data model — its origin, organization, and current applications
KPWHRI psychologist and researcher Ben Balderson, PhD, shares advice for keeping our spirits up during this most unusual holiday season.
